// App-Quantinova.ai

SAT0609-HPR : DELPHI CONSENSUS FOR THE OPTIMAL TREATMENT & MANAGEMENT OF COMPLEX RHEUMATOID ARTHRITIS (RA) PATIENTS

Researchers

Presenter

  • G. Dulay

Principal Investigators

  • E. Choy

  • T. Barnes

  • D. Chagadama

  • Z. Cole

  • A. Malaviya

  • S. Robinson

  • D. Walker

  • C. Daly

  • N. Savill

  • T. Warren

  • N. Williams

Medical Centers

  • Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Rheumatology, Portsmouth, United Kingdom

  • School of Medicine, Cardiff University, Cardiff, United Kingdom

  • Countess of Chester Hospital, Chester, United Kingdom

  • Barts Health NHS Trust, London, United Kingdom

  • Salisbury District Hospital, Rhuematology, Salisbury, United Kingdom

  • Addenbrookes University Hospital, Rheumatology, Cambridge, United Kingdom

  • CNDS, Northumbria Tyne and Wear NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom

  • Northumbria Healthcare NHS Foundation Trust & Newcastle University, Newcastle-upon-Tyne, United Kingdom

  • Roche Products Limited, Shire Park, United Kingdom

  • Triducive, St Albans, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Roche

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved